Tom Meade
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects 6
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism 4
- Internal Medicine top 2%
- Oncology top 2%
-
- Antiplatelet Therapy and Cardiovascular Diseases 4
-
- Estrogen and related hormone effects 3
-
- Gastric Cancer Management and Outcomes 3
- Blood properties and coagulation 2
- Chronic Obstructive Pulmonary Disease (COPD) Research 2
-
- Menopause: Health Impacts and Treatments 3
- Co-authors
- Peter M. RothwellJ. J. F. BelchCharles WarlowMichelle WilsonF.G.R. FowkesHisao OgawaZiyah MehtaJackie F. Price
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
Tom Meade
23 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Pharmacology 1.4k
- Cancer Research 1.0k
- Internal Medicine 211
- Oncology 1.2k
- Cardiology and Cardiovascular Medicine 659
Countries citing papers authored by Tom Meade
This map shows the geographic impact of Tom Meade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Meade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Meade more than expected).
Fields of papers citing papers by Tom Meade
This network shows the impact of papers produced by Tom Meade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Meade. The network helps show where Tom Meade may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tom Meade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2016 | 1 | |
| 3 | Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trialsbreakdown → | 2012 | 736 |
| 4 | Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trialsbreakdown → | 2012 | 628 |
| 5 | 2012 | 7 | |
| 6 | 2011 | 45 | |
| 7 | Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsbreakdown → | 2010 | 1090 |
| 8 | Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsbreakdown → | 2010 | 990 |
| 9 | 2010 | 13 | |
| 10 | 2009 | 17 | |
| 11 | 2009 | 2 | |
| 12 | 2007 | 37 | |
| 13 | 2007 | 174 | |
| 14 | 2007 | 43 | |
| 15 | 2004 | 14 | |
| 16 | 2003 | 13 | |
| 17 | 2002 | 3 | |
| 18 | 1997 | 52 | |
| 19 | 1992 | 16 | |
| 20 | 1980 | 7 |
About Tom Meade
Tom Meade is a scholar working on Internal Medicine, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 23 papers that have together received 3.9k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Cancer, Lipids, and Metabolism (4 papers), Estrogen and related hormone effects (3 papers), Gastric Cancer Management and Outcomes (3 papers), Menopause: Health Impacts and Treatments (3 papers), Blood properties and coagulation (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). The work is most often cited by research in Pharmacology (1.4k citations), Cancer Research (1.0k citations) and Internal Medicine (211 citations). Tom Meade has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Peter M. Rothwell, J. J. F. Belch, Charles Warlow, Michelle Wilson, F.G.R. Fowkes, Hisao Ogawa, Ziyah Mehta, Jackie F. Price, Bo Norrving and Carl‐Eric Elwin. Their work appears in journals such as The Lancet, Obstetrical & Gynecological Survey, Open Heart, British Journal of Haematology and The Journal of Arthroplasty.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.